Vivos (RDGL) Net Margin (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.26 Mn |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | -118,283.00 |
| Mar 31, 2025 | 1.74 Mn |
| Dec 31, 2024 | -397,898.00 |
| Sep 30, 2024 | -1.28 Mn |
| Jun 30, 2024 | 868,266.00 |
| Sep 30, 2023 | 434,659.00 |
| Jun 30, 2023 | -974,638.00 |
| Mar 31, 2023 | 671,924.00 |
| Dec 31, 2022 | -659,533.00 |
| Sep 30, 2022 | 323,782.00 |
| Jun 30, 2022 | -211,648.00 |
| Dec 31, 2019 | -2.52 Mn |
| Sep 30, 2016 | 9.93 Mn |
| Jun 30, 2016 | 4.00 Mn |
| Jun 30, 2014 | -458,465.00 |
| Mar 31, 2013 | 350,969.00 |
| Dec 31, 2012 | -232,966.00 |
| Sep 30, 2012 | 124,220.00 |
| Jun 30, 2012 | -323,012.00 |
| Mar 31, 2012 | -2,102.00 |
| Dec 31, 2011 | -53,592.00 |
| Sep 30, 2011 | 38,804.00 |
| Jun 30, 2011 | -27,054.00 |
| Mar 31, 2011 | -91,725.00 |